Comparison of intraoperative opioid use in two opioid injections by Analgesia nociception index (ANI) and conventional method

Comparison of intraoperative opioid use in two opioid injections according to the pain score determined by the Analgesia nociception index (ANI) and conventional injections in laparoscopic gynecological surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120814010599N30

Enrollment

Registered

2021-09-20

Start date

2021-08-20

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group: In the Analgesia nociception index (ANI) intervention group, control for analgesia of patients during the operation of remifentanil (Produced by Exir) will be perfo

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Candidate of laparoscopic gynecological surgery Age between 18-45 years Body mass index (BMI) less than 25

Exclusion criteria

Exclusion criteria: Having cardiac arrhythmia Patients with central or autonomic neurological problems undergoing opioid treatment

Design outcomes

Primary

Measure	Time frame
Total dose of opioid used during surgery. Timepoint: After surgery. Method of measurement: Patient file.	—

Secondary

Measure	Time frame
Pain. Timepoint: At 1, 12 and 24 hours after surgery. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPoupak Rahimzadeh

Iran University of Medical Sciences

p-rahimzadeh@tums.ac.ir+98 21 6650 9059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026